Castle Biosciences targets $345M-$355M 2026 revenue as TissueCypher volumes grow 58% and AdvanceAD-Tx reaches ~650 orders
Castle Biosciences, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $20.97
-3.2% in 3d after detection
Post-detection moves
1h
—
1d
+3.1%
3d
-3.2%
7d
+0.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS